Hanna Israelsson1, Bo Carlberg2, Carsten Wikkelsö2, Katarina Laurell2, Babar Kahlon2, Göran Leijon2, Anders Eklund2, Jan Malm2. 1. From the Departments of Pharmacology and Clinical Neuroscience (H.I., K.L., J.M.), Public Health and Clinical Medicine (B.C.), and Radiation Sciences (A.E.), and Center for Biomedical Engineering and Physics (A.E.), Umeå University; Institute of Neuroscience (C.W.), Sahlgrens Academy, University of Gothenburg; Department of Neurosurgery (B.K.), Lund University; and Department of Clinical and Experimental Medicine (IKE) (G.L.), Division of Neuroscience, Linköping University, Sweden. hanna.israelsson@umu.se. 2. From the Departments of Pharmacology and Clinical Neuroscience (H.I., K.L., J.M.), Public Health and Clinical Medicine (B.C.), and Radiation Sciences (A.E.), and Center for Biomedical Engineering and Physics (A.E.), Umeå University; Institute of Neuroscience (C.W.), Sahlgrens Academy, University of Gothenburg; Department of Neurosurgery (B.K.), Lund University; and Department of Clinical and Experimental Medicine (IKE) (G.L.), Division of Neuroscience, Linköping University, Sweden.
Abstract
OBJECTIVE: To assess the complete vascular risk factor (VRF) profile of idiopathic normal pressure hydrocephalus (INPH) using a large sample of representative patients with INPH and population-based controls to determine the extent to which vascular disease influences INPH pathophysiology. METHODS: All patients with INPH who underwent shunting in Sweden in 2008-2010 were compared to age- and sex-matched population-based controls. Inclusion criteria were age 60-85 years and no dementia. The 10 most important VRFs and cerebrovascular and peripheral vascular disease were prospectively assessed using blood samples, clinical examinations, and standardized questionnaires. Assessed VRFs were hypertension, hyperlipidemia, diabetes, obesity, psychosocial factors, smoking habits, diet, alcohol intake, cardiac disease, and physical activity. RESULTS: In total, 176 patients with INPH and 368 controls participated. Multivariable logistic regression analysis indicated that hyperlipidemia (odds ratio [OR] 2.380; 95% confidence interval [CI] 1.434-3.950), diabetes (OR 2.169; 95% CI 1.195-3.938), obesity (OR 5.428; 95% CI 2.502-11.772), and psychosocial factors (OR 5.343; 95% CI 3.219-8.868) were independently associated with INPH. Hypertension, physical inactivity, and cerebrovascular and peripheral vascular disease were also overrepresented in INPH. Moderate alcohol intake and physical activity were overrepresented among the controls. The population-attributable risk percentage was 24%. CONCLUSIONS: Our findings confirm that patients with INPH have more VRFs and lack the protective factors present in the general population. Almost 25% of cases of INPH may be explained by VRFs. This suggests that INPH may be a subtype of vascular dementia. Targeted interventions against modifiable VRFs are likely to have beneficial effects on INPH.
OBJECTIVE: To assess the complete vascular risk factor (VRF) profile of idiopathic normal pressure hydrocephalus (INPH) using a large sample of representative patients with INPH and population-based controls to determine the extent to which vascular disease influences INPH pathophysiology. METHODS: All patients with INPH who underwent shunting in Sweden in 2008-2010 were compared to age- and sex-matched population-based controls. Inclusion criteria were age 60-85 years and no dementia. The 10 most important VRFs and cerebrovascular and peripheral vascular disease were prospectively assessed using blood samples, clinical examinations, and standardized questionnaires. Assessed VRFs were hypertension, hyperlipidemia, diabetes, obesity, psychosocial factors, smoking habits, diet, alcohol intake, cardiac disease, and physical activity. RESULTS: In total, 176 patients with INPH and 368 controls participated. Multivariable logistic regression analysis indicated that hyperlipidemia (odds ratio [OR] 2.380; 95% confidence interval [CI] 1.434-3.950), diabetes (OR 2.169; 95% CI 1.195-3.938), obesity (OR 5.428; 95% CI 2.502-11.772), and psychosocial factors (OR 5.343; 95% CI 3.219-8.868) were independently associated with INPH. Hypertension, physical inactivity, and cerebrovascular and peripheral vascular disease were also overrepresented in INPH. Moderate alcohol intake and physical activity were overrepresented among the controls. The population-attributable risk percentage was 24%. CONCLUSIONS: Our findings confirm that patients with INPH have more VRFs and lack the protective factors present in the general population. Almost 25% of cases of INPH may be explained by VRFs. This suggests that INPH may be a subtype of vascular dementia. Targeted interventions against modifiable VRFs are likely to have beneficial effects on INPH.
Authors: A J Boon; J T Tans; E J Delwel; S M Egeler-Peerdeman; P W Hanlo; H A Wurzer; J Hermans Journal: J Neurosurg Date: 1999-02 Impact factor: 5.115
Authors: Shahan Momjian; Brian K Owler; Zofia Czosnyka; Marek Czosnyka; Alonso Pena; John D Pickard Journal: Brain Date: 2004-03-19 Impact factor: 13.501
Authors: Geir Ringstad; Lars M Valnes; Anders M Dale; Are H Pripp; Svein-Are S Vatnehol; Kyrre E Emblem; Kent-Andre Mardal; Per K Eide Journal: JCI Insight Date: 2018-07-12
Authors: Ville E Korhonen; Seppo Helisalmi; Aleksi Jokinen; Ilari Jokinen; Juha-Matti Lehtola; Minna Oinas; Kimmo Lönnrot; Cecilia Avellan; Anna Kotkansalo; Janek Frantzen; Jaakko Rinne; Antti Ronkainen; Mikko Kauppinen; Antti Junkkari; Mikko Hiltunen; Hilkka Soininen; Mitja Kurki; Juha E Jääskeläinen; Anne M Koivisto; Hidenori Sato; Takeo Kato; Anne M Remes; Per Kristian Eide; Ville Leinonen Journal: Neurol Genet Date: 2018-12-03
Authors: Joel Räsänen; Joel Huovinen; Ville E Korhonen; Antti Junkkari; Sami Kastinen; Simo Komulainen; Minna Oinas; Cecilia Avellan; Janek Frantzen; Jaakko Rinne; Antti Ronkainen; Mikko Kauppinen; Kimmo Lönnrot; Markus Perola; Anne M Koivisto; Anne M Remes; Hilkka Soininen; Mikko Hiltunen; Seppo Helisalmi; Mitja I Kurki; Juha E Jääskeläinen; Ville Leinonen Journal: Fluids Barriers CNS Date: 2020-09-15
Authors: Vasco Vanhala; Antti Junkkari; Ville E Korhonen; Mitja I Kurki; Mikko Hiltunen; Tuomas Rauramaa; Ossi Nerg; Anne M Koivisto; Anne M Remes; Jonna Perälä; Jaana Suvisaari; Soili M Lehto; Heimo Viinamäki; Hilkka Soininen; Juha E Jääskeläinen; Ville Leinonen Journal: Neurosurgery Date: 2019-04-01 Impact factor: 4.654